General practitioners (GPs) routinely assess conflicting symptoms of respiratory illness in their patients - and on the balance of available information and clinical judgement, often prescribe antibiotics on the spot.
As featured in an article by journalist Rachel Fieldhouse for Australian Doctor - ‘New point-of-care tests promise to pick the patients who actually need antibiotics’- Lumos’ FebriDx® rapid point-of-care diagnostic test is now approved and ready to help in Australia.
FebriDx® enables healthcare professionals to distinguish between bacterial infections and non-bacterial etiology, supporting informed decisions about antibiotic prescriptions.
Lumos Non-Executive Chair, Sam Lanyon, was interviewed for the article, reflecting on Lumos’ consultation with the Australian medical community.
“A fast, cost-effective point-of-care test would be useful to help them provide the evidence to a patient that they don’t need antibiotics and they’re not going to be effective,” he said.
“In the Australian and US context, we had exactly the same feedback. [Doctors] all articulate the same problem.”
Click here to read the article